Evidence map›Paper›PMID 41719289›Full record

ArticlePloS one2026

Boundary-aware dual-discriminator generative adversarial network for data augmentation in financial transaction fraud detection.

Honghao Zhu, Zhanchao Wang, Yu Xie, Jiamin Yao

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Honghao ZhuSchool of Computer and Information Engineering, Bengbu University, Bengbu, China.
Zhanchao WangCollege of Information Engineering, Shanghai Maritime University, Shanghai, China.
Yu XieCollege of Information Engineering, Shanghai Maritime University, Shanghai, China.ORCID https://orcid.org/0000-0002-0928-3823
Jiamin YaoCollege of Information Engineering, Shanghai Maritime University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid growth of digital payments exacerbates the challenges in Financial Transaction Fraud Detection (FTFD). These challenges stem primarily from an extreme class imbalance, where legitimate transactions greatly outnumber fraudulent ones. This imbalance significantly hampers the ability of FTFD models to accurately learn fraud patterns. Although existing data augmentation techniques have shown effectiveness in alleviating this problem, they are often negatively influenced by anomalous samples that diverge from the true fraud distribution due to fraudsters' concealment strategies and the inherent complexity of fraudulent patterns. This divergence makes it challenging to accurately model the distribution of fraudulent activities. In this work, we propose a Boundary-Aware Dual-discriminator Generative Adversarial Network (BADGAN) to address the class imbalance issue in FTFD. BADGAN integrates a boundary sample classifier with a dual-constraint mechanism based on distance adversarial learning, allowing the generator to produce synthetic samples that both adhere to the distribution of real fraud data and maintain a distance from the decision boundary. This boundary-aware design emphasizes the optimization of sample quality near classification boundaries, thereby improving the downstream classifier's ability to distinguish fraudulent behavior. Extensive experiments on both real-world and public datasets demonstrate that BADGAN outperforms its competitive peers in addressing the class imbalance issue, thereby enhancing the detection performance of FTFD models.

Indexed as

FraudAlgorithmsGenerative Adversarial NetworksGenerative Artificial IntelligenceHumans

Identifiers

PMID41719289
PMCPMC12923028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.